Indian Pharma Majors Weigh Bids For Sanofi’s $2 Billion European Generics Business

MUMBAI: Homegrown Aurobindo, Zydus Cadila, Torrent Pharma and Intas have expressed preliminary interest in buying the European generics business of Paris-headquartered pharma giant Sanofi as frenzied dealmaking continues in Big Pharma the world over in the new year.

The portfolio of acute, chronic and oncology products could fetch a valuation of $1.5-2 billion, making it among the largest outbound transactions pursued by an Indian drug company, said multiple sources in the know. 

Articles sur le même thème

No news available.

Evénements sur le même thème

Share this page Share on FacebookShare on TwitterShare on Linkedin